ARCHIVES

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

A Provision Of The EARLY Bill Is Inserted Into House Appropriations For Labor, HHS

July 24, 2009

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

January 11, 2008

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

NTP Committee Accepts Industry Positions On Policy To Separate Figures for Benign, Malignant Lesions

November 7, 1980

President Calls For Reversing Cuts to Basic Research Budget

January 31, 2014

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

April 16, 2004